Literature DB >> 104330

The effect of antidepressant drugs on plasma kynurenine in depressed patients.

K Wood, J Harwood, A Coppen.   

Abstract

The concentration of kynurenine in plasma from depressed patients and control subjects has been measured using a sensitive and specific method. The levels of kynurenine in the plasma of depressed patients and controls are not significantly different and are not influenced by age or sex. The severity of affective disturbance was not related to plasma kynurenine levels in depressed patients. Clinical outcome could not be accurately predicted by measurement of plasma kynurenine levels. Amitriptyline did not significantly increase plasma kynurenine concentration in vivo, whereas lithium and mianserin did have a significant effect. These results are discussed with reference to known abnormalities of tryptophan metabolism in depressive illness and in particular to the 5-hydroxytryptamine uptake characteristics of blood platelets in depressive patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 104330     DOI: 10.1007/bf00426632

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  CLINICAL TRIAL OF THE TREATMENT OF DEPRESSIVE ILLNESS. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS CLINICAL PSYCHIATRY COMMITTEE.

Authors:  M THIERY
Journal:  Br Med J       Date:  1965-04-03

2.  The effect of cortisone and hydrocortisone on the tryptophan peroxidase-oxidase activity of rat liver.

Authors:  J F THOMSON; E T MIKUTA
Journal:  Endocrinology       Date:  1954-08       Impact factor: 4.736

3.  Computer simulation and analysis of tryptophan metabolism via kynurenine pathway in liver.

Authors:  F Heinmets
Journal:  Comput Biol Med       Date:  1974-09       Impact factor: 4.589

4.  Cerebral tryptophan-2,3-dioxygenase (pyrrolase) and its induction in rat brain.

Authors:  E M Gál
Journal:  J Neurochem       Date:  1974-05       Impact factor: 5.372

5.  Total and free tryptophan concentration in the plasma of depressive patients.

Authors:  A Coppen; E G Eccleston; M Peet
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

6.  Plasma amino acids as an index for subgroups in manic depressive psychosis: correlation to effect of tryptophan.

Authors:  S E Moller; L Kirk; K H Fremming
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

7.  Dose-dependent dual action of kynurenine, a tryptophan metabolite, on the turnover of 5-hydroxytryptamine [proceedings].

Authors:  S E Gould; S L Handley
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

8.  Tryptophan concentrations in rat brain. Failure to correlate with free serum tryptophan or its ratio to the sum of other serum neutral amino acids.

Authors:  J D Fernstrom; M J Hirsch; D V Faller
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

9.  The determination of kynurenine in plasma.

Authors:  M H Joseph; D Risby
Journal:  Clin Chim Acta       Date:  1975-09-01       Impact factor: 3.786

10.  Effect of mianserin hydrochloride on peripheral uptake mechanisms for noradrenaline and 5-hydroxytryptamine in man.

Authors:  A Coppen; K Ghose; C Swade; K Wood
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

View more
  6 in total

1.  Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.

Authors:  Danilo Arnone; Smita Saraykar; Haitham Salem; Antonio L Teixeira; Robert Dantzer; Sudhakar Selvaraj
Journal:  Neurosci Biobehav Rev       Date:  2018-06-22       Impact factor: 8.989

Review 2.  The kynurenine pathway and the brain: Challenges, controversies and promises.

Authors:  Robert Schwarcz; Trevor W Stone
Journal:  Neuropharmacology       Date:  2016-08-07       Impact factor: 5.250

3.  New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio.

Authors:  Tomasz Kocki; Sebastian Wnuk; Renata Kloc; Janusz Kocki; Björn Owe-Larsson; Ewa M Urbanska
Journal:  J Neural Transm (Vienna)       Date:  2011-06-10       Impact factor: 3.575

4.  Tryptophan tolerance and metabolism in endogenous depression.

Authors:  S E Møller; L Kirk; P Honoré
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.

Authors:  C L Raison; R Dantzer; K W Kelley; M A Lawson; B J Woolwine; G Vogt; J R Spivey; K Saito; A H Miller
Journal:  Mol Psychiatry       Date:  2009-11-17       Impact factor: 15.992

6.  Kynurenine and depressive symptoms in a poststroke population.

Authors:  Kira Bensimon; Nathan Herrmann; Walter Swardfager; Hao Yi; Sandra E Black; Fu-Qiang Gao; Abraham Snaiderman; Krista L Lanctôt
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-22       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.